At the age of 35, I was diagnosed with stage 3 colorectal cancer. Part of the treatment, involved radiation therapy. My ovaries were a radiation zone, thus I lost both. I am fortunate to survive and thrive at 62 years.
In 1998, the recommended treatment for medically induced menopause was Prempro. However, I was concerned about long term use a conjugated equine estrogen. A local compounding pharmacy provided a course and prescriptions for Bio-identical Hormone Therapy (BHT).
In 2002 the WHI reported increased risk of stroke with conjugated estrogens.
Compounding pharmacies provide individualized treatments for patients. This is not an aim of pharmacology companies.
My story illustrates the benefits of individuals working with compounding pharmacies. It also reminds us of the short comings and sometimes harmful of effects of having a prescription industry dominated by pharmacology companies.